$FBRX·4

Tocagen Inc · Apr 21, 5:39 PM ET

Tocagen Inc 4

4 · Tocagen Inc · Filed Apr 21, 2017

Insider Transaction Report

Form 4
Period: 2017-04-19
Duvall Martin J
DirectorChief Executive Officer
Transactions
  • Other

    Common Stock

    2017-04-19$10.00/sh+3,571$35,7103,571 total
Footnotes (1)
  • [F1]Represents the conversion of outstanding convertible promissory notes in the aggregate principal amount of $35,000, plus an aggregate of $714.39 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $10.00 per share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION